Retour
Résumé des données probantes

Qu'est-ce qu'un Résumé des données probantes?

Les messages clés des recherches scientifiques sur lesquels on peut agir

J'ai compris, masquez ceci
  • Cote:

In people with recurrent depression, mindfulness-based cognitive therapy reduces relapse

Kuyken W, Warren FC, Taylor RS, et al. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials. JAMA Psychiatry. 2016;73:565-74.

Review question

In people who have recovered from recurrent depression, does mindfulness-based cognitive therapy (MBCT) prevent relapse?

Background

Depression is a common mood disorder that affects how you feel, think, and behave. Symptoms include feeling sad, losing interest in things you like to do, having trouble thinking or concentrating, and feeling anxious or restless. It is more than just being sad and may get worse if not treated.

Some people will have only one episode of depression, while others will have more than one episode (recurrent depression). In people who have fully or mostly recovered from an episode of depression, some treatments, such as MBCT, may prevent a new episode (recurrence) or worsening symptoms (relapse).

MBCT is a type of psychological therapy that focuses on meditative practices and helps you manage thinking that may be inaccurate or overly negative.

How the review was done

The review included 9 studies (randomized controlled trials) that were published in English up to November 2014. The trials included 1,258 adults who were, on average, 47 years of age. 75% were women.

People had a doctor’s diagnosis of recurrent depression. They had mostly recovered from their latest episode of depression (full or partial remission) at the start of the trials.

Trials compared MBCT with a control treatment that didn’t include MBCT. In 5 trials the control treatment was usual care or psychological education. In 4 trials, the control treatment was antidepressant drugs.

Trials didn’t report the duration of MBCT.

What the researchers found

People who had MBCT were less likely to have a relapse of depression over 60 weeks than those who had usual care or a different treatment, including antidepressant drugs.

People with more severe depression symptoms before starting MBCT may benefit most.

Conclusion

In people with recurrent depression, mindfulness-based cognitive therapy reduces relapse at 60 weeks more than usual care or another treatment.

Mindfulness-based cognitive therapy (MBCT) vs treatment without MBCT for preventing relapse in people with recurrent depression

Comparisons

Number of trials and people

Rate of relapse with MBCT

Rate of relapse with non-MBCT treatment

Effect of MBCT at  60 weeks

MBCT vs any non-MBCT treatment

9 trials (1,258 people)

38%

49%

About 12 fewer people out of 100 had a relapse of depression (from as few as 7 to as many as 17)

MBCT vs antidepressant drugs

4 trials (637 people)

Not reported

Not reported

Fewer people had a relapse of depression (relative risk reduction 23%, from as little as 2% to as much as 40%)

 




Glossaire

Randomized controlled trials
Studies where people are assigned to one of the treatments purely by chance.

Ressources Web connexes

  • Dépression

    Informed Health Online
    La dépression est un trouble de l'humeur courant qui peut rendre difficile la vie de tous les jours. Les causes et les facteurs de risque de la dépression comprennent les gènes, les expériences et les circonstances de vie difficiles, les troubles anxieux chroniques, les changements biochimiques, les problèmes médicaux et le manque de lumière. Les thérapies psychologiques (par exemple, la thérapie cognitivo-comportementale) et les médicaments, seuls ou combinés, sont des options de traitement. Cette ressource est disponible en anglais.
  • Des médicaments pour traiter la dépression: une revue des recherches pour les adultes

    OHRI
    Cet outil d'aide à la décision vise à aider les adultes diagnostiqués comme étant dépressifs à décider du type de médicament qu'ils devraient prendre. L'outil compare les avantages, les risques et les effets secondaires de chaque antidépresseur. Cette ressource est disponible en anglais.
  • Éducation des patients: le délire (au-delà des bases)

    UpToDate - patient information
    Le délire est le résultat de changements du cerveau qui mènent à la confusion, au manque de concentration et aux problèmes de mémoire. Il n'y a pas de traitement spécifique pour le délire. Il est donc préférable d'éviter les risques, de traiter les maladies sous-jacentes et de recevoir des soins de soutien. Les sédatifs et les contraintes physiques doivent être évités. Cette ressource est disponible en anglais.
AVERTISSEMENT Ces résumés sont fournis à titre informatif seulement. Ils ne peuvent pas remplacer les conseils de votre propre professionnel de la santé. Les résumés peuvent être reproduits à des fins éducatives sans but lucratif. Toute autre utilisation doit être approuvée par le Portail du vieillissement optimal de McMaster (info@mcmasteroptimalaging.org).

Voulez-vous savoir ce que lisent les professionnels? Inscrivez-vous pour accéder gratuitement à tous les contenus professionnels.

S'inscrire